Literature DB >> 29702279

Cordycepin alleviates lipopolysaccharide-induced acute lung injury via Nrf2/HO-1 pathway.

Rui Qing1, Zezhi Huang1, Yufei Tang1, Qingke Xiang1, Fan Yang2.   

Abstract

AIMS: The present study is to investigate the protective effect of cordycepin on inflammatory reactions in rats with acute lung injury (ALI) induced by lipopolysaccharide (LPS), as well as the underlying mechanism.
METHODS: Wistar rat model of ALI was induced by intravenous injection of LPS (30 mg/kg body weight). One hour later, intravenous injection of cordycepin (1, 10 or 30 mg/kg body weight) was administered. The wet-to-dry weight ratio of lung tissues and myeloperoxidase activity in the lung tissues were measured. The contents of nitrite and nitrate were measured by reduction method, while chemiluminescence was used to determine the content of superoxide. Quantitative real-time polymerase chain reaction and Western blotting were used to determine the expression of mRNA and protein, respectively. Colorimetry was performed to determine the enzymatic activity of heme oxygenase-1 (HO-1). Nuclear translocation of Nrf2 was identified by Western blotting. The plasma contents of cytokines were measured by enzyme-linked immunosorbent assay.
RESULTS: Cordycepin enhanced the expression and enzymatic activity of HO-1 in ALI rats, and activated Nrf2 by inducing the translocation of Nrf2 from cytoplasm to nucleus. In addition, cordycepin regulated the secretion of TNF-α, IL-6 and IL-10 via HO-1, and suppressed inflammation in lung tissues of ALI rats by inducing the expression of HO-1. HO-1 played important roles in the down-regulation of superoxide levels in lung tissues by cordycepin, and HO-1 expression induced by cordycepin affected nitrite and nitrate concentrations in plasma and iNOS protein expression in lung tissues. Cordycepin showed protective effect on injuries in lung tissues.
CONCLUSION: The present study demonstrates that cordycepin alleviates inflammation induced by LPS via the activation of Nrf2 and up-regulation of HO-1 expression.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acute lung injury; Cordycepin; Heme oxygenase‑1; Lipopolysaccharide; Nrf2

Mesh:

Substances:

Year:  2018        PMID: 29702279     DOI: 10.1016/j.intimp.2018.04.032

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  6 in total

Review 1.  Natural product derived phytochemicals in managing acute lung injury by multiple mechanisms.

Authors:  Yu-Qiong He; Can-Can Zhou; Lu-Yao Yu; Liang Wang; Jiu-Ling Deng; Yu-Long Tao; Feng Zhang; Wan-Sheng Chen
Journal:  Pharmacol Res       Date:  2020-09-29       Impact factor: 7.658

Review 2.  Role of Nrf2 and Its Activators in Respiratory Diseases.

Authors:  Qinmei Liu; Yun Gao; Xinxin Ci
Journal:  Oxid Med Cell Longev       Date:  2019-01-08       Impact factor: 6.543

3.  Ameliorative effects of silymarin on HCl-induced acute lung injury in rats; role of the Nrf-2/HO-1 pathway.

Authors:  Rasha F Ahmed; Rabab A Moussa; Reda S Eldemerdash; Mahmoud M Zakaria; Seham A Abdel-Gaber
Journal:  Iran J Basic Med Sci       Date:  2019-12       Impact factor: 2.699

Review 4.  A Systematic Review of the Biological Effects of Cordycepin.

Authors:  Masar Radhi; Sadaf Ashraf; Steven Lawrence; Asta Arendt Tranholm; Peter Arthur David Wellham; Abdul Hafeez; Ammar Sabah Khamis; Robert Thomas; Daniel McWilliams; Cornelia Huiberdina de Moor
Journal:  Molecules       Date:  2021-09-28       Impact factor: 4.411

5.  Systems pharmacology reveals the mechanism of activity of Physalis alkekengi L. var. franchetii against lipopolysaccharide-induced acute lung injury.

Authors:  Yanni Yang; Zihe Ding; Yi Wang; Renxing Zhong; Yanlin Feng; Tianyi Xia; Yuanyuan Xie; Bingyou Yang; Xiaobo Sun; Zunpeng Shu
Journal:  J Cell Mol Med       Date:  2020-03-27       Impact factor: 5.310

6.  Sufentanil attenuates inflammation and oxidative stress in sepsis-induced acute lung injury by downregulating KNG1 expression.

Authors:  Quan Hu; Qin Wang; Chuangang Han; Yan Yang
Journal:  Mol Med Rep       Date:  2020-09-18       Impact factor: 2.952

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.